NasdaqCM - Nasdaq Real Time Price • USD
Applied DNA Sciences, Inc. (APDN)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 6:45 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 2 | 2 | 2 | 2 |
Avg. Estimate | -4.5 | -3.7 | -13 | -10.6 |
Low Estimate | -4.6 | -4 | -13.4 | -11.6 |
High Estimate | -4.4 | -3.4 | -12.6 | -9.6 |
Year Ago EPS | 1 | -4.8 | -15.2 | -13 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 2 | 2 | 2 | 2 |
Avg. Estimate | 950k | 1.18M | 5.02M | 8.17M |
Low Estimate | 900k | 950k | 3.94M | 7.05M |
High Estimate | 1M | 1.41M | 6.1M | 9.29M |
Year Ago Sales | -- | -- | 13.37M | 5.02M |
Sales Growth (year/est) | -- | -- | -62.40% | 62.70% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | -4 | -4.8 | -5.4 | -6.2 |
EPS Actual | 1 | -4.8 | -5.2 | -1.8 |
Difference | 5 | 0 | 0.2 | 4.4 |
Surprise % | 125.00% | 0.00% | 3.70% | 71.00% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | -4.5 | -3.7 | -13 | -10.6 |
7 Days Ago | -0.22 | -0.18 | -0.65 | -0.53 |
30 Days Ago | -0.22 | -0.18 | -0.65 | -0.53 |
60 Days Ago | -0.22 | -0.18 | -0.65 | -0.53 |
90 Days Ago | -0.22 | -0.16 | -0.83 | -0.57 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | APDN | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -550.00% | -- | -- | 6.50% |
Next Qtr. | 22.90% | -- | -- | 12.00% |
Current Year | 14.50% | -- | -- | 5.30% |
Next Year | 18.50% | -- | -- | 13.10% |
Next 5 Years (per annum) | -- | -- | -- | 11.09% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Maintains | HC Wainwright & Co.: Buy to Buy | 2/9/2024 |
Maintains | HC Wainwright & Co.: Buy to Buy | 12/8/2023 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 8/24/2023 |
Maintains | HC Wainwright & Co.: Buy to Buy | 8/14/2023 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 7/14/2023 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 5/12/2023 |
Related Tickers
ISPC iSpecimen Inc.
0.2660
-5.07%
TTOO T2 Biosystems, Inc.
2.8400
+3.65%
MYNZ Mainz Biomed N.V.
0.8181
-4.52%
GENE Genetic Technologies Limited
2.2210
+1.88%
DMTK DermTech, Inc.
0.6031
+3.02%
PRE Prenetics Global Limited
4.6100
-7.24%
ME 23andMe Holding Co.
0.4641
+1.11%
LAB Standard BioTools Inc.
2.4400
+3.39%
CHEK Check-Cap Ltd.
2.2850
-0.65%
NVTAQ Invitae Corporation
0.0005
-94.44%